callahamirykaan1884.blogspot.com
The company announced Friday that Fargo wouldr replace current CEO John Garibaldi as of Garibaldi will remain as vice chairman and a membeer of the boardof directors. Fargo is former commander of the U.S. Pacifix Command and commander-in-chief of the U.S. Pacific Fleet. He retired in 2005 aftere 35 years ofmilitary service. He has resignerd as CEO of Honolulu-based , a high-bandwidth wirelesas communications company, and as president of Loea's parent San Diego-based high-tech company . He will remain on the Trex boarfdof directors, according to Linda Jameson, a spokeswoman for Loea. He also will remain on the boarx of directorsof , a defensde and homeland security company.
Fargo also is managing directorrof J.F. Lehman & Co., a major investof in the Superferry headed byformere U.S. Navy secretary John F. Lehman, who is also chairman of the Superferry'xs board of directors. Fargo is on the boars of , and the .
Thursday, June 7, 2012
Wednesday, June 6, 2012
Early Theater of Shakespeare Is Unearthed in London - New York Times (blog)
paramonaxogilozi.blogspot.com
New York Times (blog) | Early Theater of Shakespeare Is Unearthed in London New York Times (blog) By DAVE ITZKOFF Museum of London Archaeology/Associated Press An archaeologist excavating the site of the Curtain Theater in London in October 2011. The tomb of William Shakespeare in Stratford-on-Avon may warn the inquisitive (and the morbid) not รข€œto ... Early Shakespeare theatre unearthed in London Early Shakespeare theatre unearthed Shakespeare's pre-Globe theater unearthed |
Monday, June 4, 2012
Menswear shop seeks to fashion a female clientele - Nashville Business Journal:
xiwyxucupewox.blogspot.com
Smith and Pagel, owners of , a high-en menswear store they launched in the Centralo West Endin 2006, are looking for pursees to boost their sales. Women, they said, tend to be biggef shoppers even when it comesto men’d clothing. “Where we run into problems is motivating them to take the next step to come Smith said. The 28-year-olds posted a small profit in 2008 and are on traci toreach $500,000 in sales this year. Last the shop almost doubled in sizeto 1,473 square feet with a move to 26 Marylanfd Plaza. The store carries European-cut designer including Hugo Boss and Ted as well as Ike Behardresss shirts, and upscale denim brands.
The business partners said their effortss to attract women shoppers throughfashionh shows, direct mail and theirt Web site have not increased Their challenge: How to make the most of thei marketing money to attract this Peter Edison’s advice: “Create an event for women the same way jewelry stores create an evenf for men to shop. Use a customef mailing list to notify them of the and follow up with aphonew call.” Anna Spector’s advice: “Startf a gift registry for men. Women’s stores have been doin g it for years.” Elains Burkhardt’s advice: “Plan a promotion for Father’ss Day.
Participate in charity events; offer to dress the chairperso n or MC ofthe event; it’s grea exposure and PR.” Susan Seymour’xs advice: “Post pictures from the fashion shows on the store’s Web Take it even furtheer with Facebook or MySpace, where guys can go for advicw and pictures of ‘what to wear where.’”
Smith and Pagel, owners of , a high-en menswear store they launched in the Centralo West Endin 2006, are looking for pursees to boost their sales. Women, they said, tend to be biggef shoppers even when it comesto men’d clothing. “Where we run into problems is motivating them to take the next step to come Smith said. The 28-year-olds posted a small profit in 2008 and are on traci toreach $500,000 in sales this year. Last the shop almost doubled in sizeto 1,473 square feet with a move to 26 Marylanfd Plaza. The store carries European-cut designer including Hugo Boss and Ted as well as Ike Behardresss shirts, and upscale denim brands.
The business partners said their effortss to attract women shoppers throughfashionh shows, direct mail and theirt Web site have not increased Their challenge: How to make the most of thei marketing money to attract this Peter Edison’s advice: “Create an event for women the same way jewelry stores create an evenf for men to shop. Use a customef mailing list to notify them of the and follow up with aphonew call.” Anna Spector’s advice: “Startf a gift registry for men. Women’s stores have been doin g it for years.” Elains Burkhardt’s advice: “Plan a promotion for Father’ss Day.
Participate in charity events; offer to dress the chairperso n or MC ofthe event; it’s grea exposure and PR.” Susan Seymour’xs advice: “Post pictures from the fashion shows on the store’s Web Take it even furtheer with Facebook or MySpace, where guys can go for advicw and pictures of ‘what to wear where.’”
Sunday, June 3, 2012
Human Genome Sciences shares jump on test results - Washington Business Journal:
ejyceh.wordpress.com
The company said that, afte r four years, a mid-stage clinical trial of its formeer LymphoStat-B lupus drug, now callede belimumab and brandedas Benlysta, helped improve the conditions of 57 perceny of systemic lupus erythematosus patients, compared to 46 percent of patients after only one year. Humann Genome Sciences (NASDAQ: HGSI) also saw a significant decreases in side effects betweenthe one-year and four-yeafr assessments.
The news gave some comfort to investors, who have been skepticall of thelupus drug’s chances for With trading volumes at nearly six times dailuy averages, investors drove Human Genome stock up by as much as 28 perceng since Thursday’s opening bell before it settler at $3.22, a 19 percent bump, by late afternoon. the company will underglo a more rigorous test on Wall Streernext month, when it expects to release the firsf batch of results from a late-stage clinical trial of belimumab. The secon batch is slated for aNovembefr release.
Human Genome Sciences is in the final stages of conductintgtwo third-phase trials, each with more than 800 One is lasting for 76 weeks and another for 52 weeks, though both will be measured for theitr effectiveness at 52 weeks. Lupus, whicbh hasn’t seen a new treatmentt on the market in the last five offers some inviting market share to the first company toreversed that, but analysts have brushed off Humanm Genome Sciences’ chances as being unlikely give n how difficult of a diseaswe lupus is to treat. In California-based Genentech Inc.
and Massachusetts-based Biogen Idec racked up one of the most recentf failuresin third-stage clinical trials for a drug to treayt lupus nephritis, a kidney inflammation that’w a complication of systemic lupus erythematosus. Human Genomew Sciences’ initial Phase II triall for belimumab was conducted with 449 patients in 2005 in a triaplthat hadn’t achieved everything it had set out to do, thougj patients were measured after less than a year in some casesd at that time. The company continueds to track patients who volunteeredd to remain in the midstagetrials -- 345 or 77 percent, after 52 296 patients, or 66 percent, aftedr 76 weeks; and 213 or 47 percent, as of June 1.
The company said that, afte r four years, a mid-stage clinical trial of its formeer LymphoStat-B lupus drug, now callede belimumab and brandedas Benlysta, helped improve the conditions of 57 perceny of systemic lupus erythematosus patients, compared to 46 percent of patients after only one year. Humann Genome Sciences (NASDAQ: HGSI) also saw a significant decreases in side effects betweenthe one-year and four-yeafr assessments.
The news gave some comfort to investors, who have been skepticall of thelupus drug’s chances for With trading volumes at nearly six times dailuy averages, investors drove Human Genome stock up by as much as 28 perceng since Thursday’s opening bell before it settler at $3.22, a 19 percent bump, by late afternoon. the company will underglo a more rigorous test on Wall Streernext month, when it expects to release the firsf batch of results from a late-stage clinical trial of belimumab. The secon batch is slated for aNovembefr release.
Human Genome Sciences is in the final stages of conductintgtwo third-phase trials, each with more than 800 One is lasting for 76 weeks and another for 52 weeks, though both will be measured for theitr effectiveness at 52 weeks. Lupus, whicbh hasn’t seen a new treatmentt on the market in the last five offers some inviting market share to the first company toreversed that, but analysts have brushed off Humanm Genome Sciences’ chances as being unlikely give n how difficult of a diseaswe lupus is to treat. In California-based Genentech Inc.
and Massachusetts-based Biogen Idec racked up one of the most recentf failuresin third-stage clinical trials for a drug to treayt lupus nephritis, a kidney inflammation that’w a complication of systemic lupus erythematosus. Human Genomew Sciences’ initial Phase II triall for belimumab was conducted with 449 patients in 2005 in a triaplthat hadn’t achieved everything it had set out to do, thougj patients were measured after less than a year in some casesd at that time. The company continueds to track patients who volunteeredd to remain in the midstagetrials -- 345 or 77 percent, after 52 296 patients, or 66 percent, aftedr 76 weeks; and 213 or 47 percent, as of June 1.
Friday, June 1, 2012
Austin Business Journal:
domnaofyvisyhojo.blogspot.com
James Brawner has joined Journyx Inc. as director of marketing. Brawner was previouslu director of sales and marketing with Convergent Bob Carlton has been named vice presidentg of marketing forLibreDigital . Carlton was previouslyy an executivewith CourseSmart, Thomson, HarperCollins Publishers. George Chedzhemov has been named director of servicesat LibreDigital. Chedzhemof was previously part of service deliverg managementwith OpSource. John Hale has joinerd LibreDigital assales manager. Hale previously handled salewsat RightsLine. Sean Ramsey has joined LibreDigita as director ofproduct marketing. Ramsey was previously a directoer withAlchemy Systems.
Roger Tarras has been namedd directorof sales, Americas for LibreDigital. Tarrasw was previously a sales executivwwith IBM. Dave Perryh has joined Zebra Imaging as executive vice president of commerciak markets andstrategic partnerships. Perry was previously executivwe vice president and general manager in the managemen systems division ofAvocent
James Brawner has joined Journyx Inc. as director of marketing. Brawner was previouslu director of sales and marketing with Convergent Bob Carlton has been named vice presidentg of marketing forLibreDigital . Carlton was previouslyy an executivewith CourseSmart, Thomson, HarperCollins Publishers. George Chedzhemov has been named director of servicesat LibreDigital. Chedzhemof was previously part of service deliverg managementwith OpSource. John Hale has joinerd LibreDigital assales manager. Hale previously handled salewsat RightsLine. Sean Ramsey has joined LibreDigita as director ofproduct marketing. Ramsey was previously a directoer withAlchemy Systems.
Roger Tarras has been namedd directorof sales, Americas for LibreDigital. Tarrasw was previously a sales executivwwith IBM. Dave Perryh has joined Zebra Imaging as executive vice president of commerciak markets andstrategic partnerships. Perry was previously executivwe vice president and general manager in the managemen systems division ofAvocent
Subscribe to:
Posts (Atom)